247 filings
Page 9 of 13
8-K
tve92
17 Dec 10
Other Events
12:00am
8-K
alue15wj
1 Nov 10
Seattle Genetics Reports Third Quarter 2010 Financial Results
12:00am
8-K
wr9jhpgn3 e79lv
12 Oct 10
Seattle Genetics and Millennium Announce Positive Top-Line
12:00am
8-K
6fh0nrbyr6l4m7rlyr3c
1 Oct 10
Departure of Directors or Certain Officers
12:00am
8-K
jz0im9f1io0 pen
27 Sep 10
Other Events
12:00am
8-K
wj6dp7qcuggtzzxf7lh
13 Sep 10
Seattle Genetics Announces Phase IIb Trial of Lintuzumab (SGN-33) in Patients with Acute Myeloid Leukemia (AML) Did Not Meet Primary Endpoint
12:00am
8-K
mdt4r78ie9mj8j7
27 Jul 10
Seattle Genetics Reports Second Quarter 2010 Financial Results and Continued Pipeline Progress
12:00am
8-K
jyzdxzh 1z6zwo
26 May 10
Departure of Directors or Certain Officers
12:00am
8-K
sg9yqsjwitlcign75t5h
27 Apr 10
Seattle Genetics Reports First Quarter 2010 Financial Results
12:00am
8-K
rkjsw 908xp
12 Feb 10
Departure of Directors or Certain Officers
12:00am
8-K
3j29h67mw 182jlmc5
9 Feb 10
Seattle Genetics Reports Fourth Quarter and Year 2009 Financial Results
12:00am
8-K
kmzz0
23 Dec 09
Other Events
12:00am
8-K
so31hdxkzlodjldnc7g0
15 Dec 09
Entry into a Material Definitive Agreement
12:00am
8-K
q1fbvp
11 Dec 09
Termination of a Material Definitive Agreement
12:00am
8-K
k9amuqmd cb
23 Nov 09
Entry into a Material Definitive Agreement
12:00am
8-K
ek1c4rgihmz67z3
22 Oct 09
Seattle Genetics Highlights Pipeline Progress and Reports Third Quarter 2009 Financial Results
12:00am
8-K
r6y8do
5 Oct 09
Seattle Genetics Announces Discontinuation of Dacetuzumab Phase IIb
12:00am
8-K
unz7z39byuh
12 Aug 09
Other Events
12:00am
8-K
mqk2l4epug7qm2pc 7q
23 Jul 09
Seattle Genetics Reports Strong Pipeline Progress and Second Quarter 2009 Financial Results
12:00am
8-K
dpj48v 3xcox
21 May 09
Unregistered Sales of Equity Securities
12:00am